| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $38.2B | $14.3B |
| Cost of Revenue | $215.0B | $182.5B | $133.8B | $124.8B | $117.6B | $103.5B | $97.7B | $4.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $14.6B | $14.8B | $14.8B | $13.2B | $13.0B | $14.1B | $14.1B | $11.9B |
| Operating Income | $9.2B | $9.4B | $8.5B | $8.4B | $7.9B | $8.2B | $8.1B | $4.2B |
| Net Income | $6.0B | $3.8B | $5.4B | $6.7B | $5.4B | $8.5B | $5.1B | $2.6B |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.54 | $15.87 | $23.17 | $2.63 | $0.56 |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.30 | $15.73 | $22.96 | $2.60 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B | $155.5B | $155.8B | $153.2B |
| Current Assets | $47.8B | $48.9B | $37.4B | $30.1B | $36.1B | $27.8B | $29.8B | $20.4B |
| Cash & Equivalents | $7.7B | $7.5B | $7.8B | $5.9B | $5.1B | $10.2B | $4.6B | $3.9B |
| Total Liabilities | $116.0B | $114.6B | $106.4B | $99.0B | $107.7B | $105.1B | $110.4B | $112.2B |
| Current Liabilities | $56.3B | $58.0B | $48.7B | $41.2B | $43.6B | $36.0B | $40.1B | $31.9B |
| Stockholders' Equity | $41.7B | $41.0B | $46.2B | $44.9B | $47.1B | $50.3B | $45.3B | $41.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B | $10.3B | $9.5B | $3.8B |
| Investing Cash Flow | $-4.4B | $-2.1B | $-5.2B | $3.1B | $-3.6B | $3.0B | $-0.7B | $-26.4B |
| Capital Expenditures | — | — | — | — | — | — | $1.1B | $0.5B |
| Financing Cash Flow | $-6.4B | $-7.6B | $-4.3B | $-11.2B | $-8.2B | $-8.5B | $-7.2B | $23.5B |